Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 2
1 (33.3%)Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Colorectal CancerColorectal Adenomatous PolypColorectal Neoplasms
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Jubaan Ltd.
- Target Recruit Count
- 800
- Registration Number
- NCT06688110
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
Evaluation of Gixam's Performance in a FIT Negative Population
Phase 2
Recruiting
- Conditions
- Colorectal AdenomaColorectal Cancer (CRC)Colorectal Cancer (CRC) Screening
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Jubaan Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT06612281
- Locations
- 🇺🇸
The Oregon Clinic Gastroenterology-East, Portland, Oregon, United States
Predicting Adenomatous Polyps in the Colon Using Images of a Human Tongue
Not Applicable
Completed
- Conditions
- Gastrointestinal MicrobiomeColorectal Neoplasms
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Jubaan Ltd.
- Target Recruit Count
- 426
- Registration Number
- NCT06305364
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸Westside GI, New York, New York, United States
🇺🇸NewYork-Presbyterian / Columbia University Irving Medical Center, New York, New York, United States
News
No news found